theory clinical_46_10
imports Main

begin

typedecl entity
typedecl event

consts
  PARPInhibitors :: "entity ⇒ bool"
  Breaks :: "entity ⇒ bool"
  ReplicationAssociated :: "entity ⇒ bool"
  DoubleStrand :: "entity ⇒ bool"
  Cause :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  Prevent :: "event ⇒ bool"
  Repair :: "entity ⇒ bool"
  SingleStrand :: "entity ⇒ bool"
  Break :: "entity ⇒ bool"
  Means :: "event ⇒ event ⇒ bool"
  Force :: "event ⇒ bool"
  Cells :: "entity ⇒ bool"
  Rely :: "event ⇒ bool"
  HomologousRecombination :: "entity ⇒ bool"
  Defective :: "entity ⇒ bool"
  EndJoining :: "entity ⇒ bool"
  NonHomologous :: "entity ⇒ bool"
  ErrorProne :: "entity ⇒ bool"
  DNA :: "entity ⇒ bool"
  SyntheticLethality :: "entity ⇒ bool"
  Occur :: "event ⇒ bool"
  CoOccurrence :: "entity ⇒ bool"
  Events :: "entity ⇒ bool"
  Genetic :: "entity ⇒ bool"
  Multiple :: "entity ⇒ bool"
  Loss :: "entity ⇒ bool"
  PALB2 :: "entity ⇒ bool"
  SuchAs :: "entity ⇒ entity ⇒ bool"
  Result :: "event ⇒ bool"
  Death :: "entity ⇒ bool"
  Cell :: "entity ⇒ bool"
  Mechanism :: "entity ⇒ bool"
  Singular :: "entity ⇒ bool"
  Damage :: "entity ⇒ bool"
  Cumulative :: "entity ⇒ bool"
  Reason :: "event ⇒ event ⇒ bool"
  InCells :: "entity ⇒ entity ⇒ bool"
  Inhibition :: "entity ⇒ bool"
  PARP1 :: "entity ⇒ bool"
  Combine :: "event ⇒ bool"
  Lead :: "event ⇒ bool"
  Inadequate :: "entity ⇒ bool"
  Window :: "entity ⇒ bool"
  Therapeutic :: "entity ⇒ bool"
  Benefit :: "event ⇒ bool"
  Patients :: "entity ⇒ bool"
  Source :: "event ⇒ entity ⇒ bool"
  Treatment :: "entity ⇒ bool"
  Create :: "event ⇒ bool"

(* Explanation 1: PARP inhibitors cause replication‐associated double-strand breaks by preventing single-strand break repair, which forces cells to rely on defective homologous recombination repair and error-prone non-homologous end joining to repair DNA. *)
axiomatization where
  explanation_1: "∃x y z w v u e1 e2 e3 e4. PARPInhibitors x ∧ Breaks y ∧ ReplicationAssociated y ∧ DoubleStrand y ∧ Cause e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Prevent e2 ∧ Repair z ∧ SingleStrand z ∧ Break z ∧ Means e1 e2 ∧ Force e3 ∧ Agent e3 x ∧ Patient e3 x ∧ Rely e4 ∧ Agent e4 x ∧ Repair w ∧ HomologousRecombination w ∧ Defective w ∧ EndJoining v ∧ NonHomologous v ∧ ErrorProne v ∧ Repair w ∧ Repair v ∧ DNA u"

(* Explanation 2: Synthetic lethality occurs when the co-occurrence of multiple genetic events, such as the loss of PALB2, results in cell death due to the reliance on a singular mechanism to repair cumulative DNA damage. *)
axiomatization where
  explanation_2: "∃x y z w v e1 e2 e3. SyntheticLethality x ∧ Occur e1 ∧ CoOccurrence y ∧ Events y ∧ Genetic y ∧ Multiple y ∧ Loss z ∧ PALB2 z ∧ SuchAs y z ∧ Result e2 ∧ Agent e2 y ∧ Patient e2 z ∧ Cell z ∧ Rely e3 ∧ Mechanism w ∧ Singular w ∧ Repair w ∧ Damage v ∧ Cumulative v ∧ DNA v ∧ Reason e2 e3"

(* Explanation 3: The loss of PALB2 in cells, when combined with PARP1 inhibition, directly leads to reliance on a singular, often inadequate, DNA repair mechanism, resulting in synthetic lethality and cell death. *)
axiomatization where
  explanation_3: "∃x y z e1 e2 e3. Loss x ∧ PALB2 x ∧ InCells x y ∧ Inhibition y ∧ PARP1 y ∧ Combine e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Lead e2 ∧ Agent e2 x ∧ Rely e3 ∧ Mechanism z ∧ Singular z ∧ Inadequate z ∧ Repair z ∧ Result e2 ∧ SyntheticLethality x ∧ Result e2 ∧ Death x ∧ Cell x"

(* Explanation 4: When cells with a loss of PALB2 rely on a singular DNA repair mechanism due to PARP1 inhibition, this can create a therapeutic window where patients may benefit from the treatment, as the inadequate repair mechanism leads to cell death. *)
axiomatization where
  explanation_4: "∃x y z w v u e1 e2 e3 e4 e5. Cells x ∧ Loss y ∧ PALB2 y ∧ InCells y x ∧ Rely e1 ∧ Agent e1 x ∧ Mechanism z ∧ Singular z ∧ Repair z ∧ Inhibition w ∧ PARP1 w ∧ Reason e1 e2 ∧ Create e2 ∧ Agent e2 x ∧ Window e3 ∧ Therapeutic e3 ∧ Patient e2 e3 ∧ Benefit e4 ∧ Patients v ∧ Agent e4 v ∧ Treatment u ∧ Source e4 u ∧ Lead e5 ∧ Agent e5 z ∧ Patient e5 x ∧ Cell x ∧ Inadequate z"

theorem hypothesis:
  assumes asm: "Patients x ∧ Loss y ∧ Inhibition z ∧ PARP1 z"
  (* Hypothesis: Patients with loss of PALB2 may benefit from PARP1 inhibition due to synthetic lethality causing cells to rely on a singular mechanism to repair cumulative damage to DNA. *)
  shows "∃x y z w v e1 e2 e3. Patients x ∧ Loss y ∧ Inhibition z ∧ PARP1 z ∧ Benefit e1 ∧ Agent e1 x ∧ Source e1 z ∧ SyntheticLethality e2 ∧ Cause e2 e3 ∧ Rely e3 ∧ Agent e3 x ∧ Mechanism w ∧ Singular w ∧ Repair w ∧ Damage v ∧ Cumulative v ∧ DNA v"
proof -
  (* From the premise, we have known information about patients, loss, inhibition, and PARP1. *)
  from asm have "Patients x ∧ Loss y ∧ Inhibition z ∧ PARP1 z" <ATP>
  (* Explanation 3 and Explanation 4 are relevant to the hypothesis. *)
  (* Explanation 3: The loss of PALB2 in cells, when combined with PARP1 inhibition, directly leads to reliance on a singular, often inadequate, DNA repair mechanism, resulting in synthetic lethality and cell death. *)
  (* Explanation 4: When cells with a loss of PALB2 rely on a singular DNA repair mechanism due to PARP1 inhibition, this can create a therapeutic window where patients may benefit from the treatment, as the inadequate repair mechanism leads to cell death. *)
  (* Logical relation: Implies(And(G, H), K) *)
  (* We can infer the therapeutic window where patients may benefit from the treatment. *)
  then have "therapeutic window where patients may benefit from the treatment" <ATP>
  (* Explanation 2: Synthetic lethality occurs when the co-occurrence of multiple genetic events, such as the loss of PALB2, results in cell death due to the reliance on a singular mechanism to repair cumulative DNA damage. *)
  (* Logical relation: Implies(And(E, F), D) *)
  (* We can infer synthetic lethality occurs. *)
  then have "synthetic lethality occurs" <ATP>
  (* Combine the results to show the hypothesis. *)
  then show ?thesis <ATP>
qed

end
